Understand the source comparison
Tesofensine Legal 2026 Status: International Comparison
United States (FDA) Investigational compound; no approval for human use Research chemical suppliers for laboratory use only No active Phase III trials as of 2026 Legal for research; illegal for human consumption or therapeutic marketing European Union (EMA) In
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- United States (FDA)
- Investigational compound; no approval for human use
- Research chemical suppliers for laboratory use only
- No active Phase III trials as of 2026
- Legal for research; illegal for human consumption or therapeutic marketing
- European Union (EMA)
- Investigational; orphan drug designation withdrawn 2010
- Research supply through licensed chemical vendors
- No active European trials since NeuroSearch discontinuation
- Same research-only framework as U.S.; no therapeutic approval
- Australia (TGA)
- Unapproved therapeutic good
- Restricted to approved research protocols with institutional ethics clearance
- No domestic trials active
- Possession without research credentials considered illegal importation
- Canada (Health Canada)
- Not authorized for sale or therapeutic use
- Available through research chemical suppliers with proper documentation
- No Canadian trials recruiting
- Research access permitted; personal importation prosecuted as unapproved drug
- No major regulatory body has approved tesofensine for human therapeutic use. The compound's international legal status mirrors the U.S. framework: permissible for documented scientific research, prohibited for personal consumption or commercial sale as a drug product.